{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:26:53Z","timestamp":1791260813627,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor metabolism, a crucial component in cancer progression, represents a potential prognostic and diagnostic platform in cancer detection. Here, we show that patient-specific stromal mesenchymal cells exhibit distinct behaviors in promoting either tumor growth or dissemination. Tumor-associated fibroblasts (TAFs) isolated from non-metastasized colorectal adenocarcinomas predominantly supported cancer cell proliferation, whereas TAFs isolated from metastatic adenocarcinomas facilitated cancer cell migration. An in vitro analysis of stromal paracrine factors revealed that variations in mitochondrial activity and the secretion of specific metabolites were closely associated with distinct tumor-stroma interactions. Among the oncometabolites identified, we validated amino acid expression in urine samples from 19 colon cancer patients to assess their potential as diagnostic biomarkers. Our results showed patient-specific alterations in oncometabolite expression, which were significantly different from those of healthy control individuals. The specificity, sensitivity, and accuracy analysis indicated 93\u2013100% specificity, 74\u201382% sensitivity, and 84\u201389% accuracy of single metabolites in distinguishing cancer patients from healthy controls. While no false negatives were observed, urine samples from nine patients with various inflammatory conditions (including diverticulitis, appendicitis, and chronic gastritis) yielded false positives. Sensitivity analysis and the t-Distributed Stochastic Neighbor Embedding (t-SNE) nonlinear dimensionality reduction technique revealed distinct metabolite profiles for healthy controls, colon cancer patients, and patients diagnosed with inflammation. Overall, our findings suggest that the identified oncometabolites, when integrated into a biomarker panel, hold promise as a novel non-invasive tool for screening individuals at risk of cancer and inflammatory malignancies.<\/jats:p>","DOI":"10.1038\/s41420-026-03172-1","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:45:30Z","timestamp":1779435930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oncometabolite signatures from tumor-stroma crosstalk as potential non-invasive biomarkers"],"prefix":"10.1038","volume":"12","author":[{"given":"Alessia","family":"Parascandolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Magnifico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5836-4497","authenticated-orcid":false,"given":"Peiman","family":"Hematti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1073-2390","authenticated-orcid":false,"given":"Cosimo","family":"Distante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Corcione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Varelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4621-2135","authenticated-orcid":false,"given":"Francesca","family":"Cutruzzol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Macone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1004-7131","authenticated-orcid":false,"given":"Mikko O.","family":"Laukkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"3172_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02123-0","volume":"19","author":"L-J Cao","year":"2021","unstructured":"Cao L-J, Peng X-L, Xue W-Q, Zhang R, Zhang J-B, Zhou T, et al. A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort study. BMC Med. 2021;19:250.","journal-title":"BMC Med"},{"key":"3172_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12876-022-02470-z","volume":"22","author":"H Xu","year":"2022","unstructured":"Xu H, Chen H, Hu J, Xiong Z, Li D, Wang S, et al. Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection. BMC Gastroenterol. 2022;22:384.","journal-title":"BMC Gastroenterol"},{"key":"3172_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/bcr772","volume":"6","author":"P Schedin","year":"2004","unstructured":"Schedin P, Elias A. Multistep tumorigenesis and the microenvironment. Breast Cancer Res. 2004;6:93\u2013101.","journal-title":"Breast Cancer Res"},{"key":"3172_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4824573","volume":"2016","author":"F Cammarota","year":"2016","unstructured":"Cammarota F, Laukkanen MO. Mesenchymal Stem\/Stromal Cells in Stromal Evolution and Cancer Progression. Stem Cells Int. 2016;2016:4824573.","journal-title":"Stem Cells Int"},{"key":"3172_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143765","volume":"131","author":"KJ Metcalf","year":"2021","unstructured":"Metcalf KJ, Alazzeh A, Werb Z, Weaver VM. Leveraging microenvironmental synthetic lethalities to treat cancer. J Clin Invest. 2021;131:e143765.","journal-title":"J Clin Invest"},{"key":"3172_CR6","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/stem.1361","volume":"31","author":"MD Castellone","year":"2013","unstructured":"Castellone MD, Laatikainen LE, Laurila JP, Langella A, Hematti P, Soricelli A, et al. Brief report: Mesenchymal stromal cell atrophy in coculture increases aggressiveness of transformed cells. Stem Cells. 2013;31:1218\u201323.","journal-title":"Stem Cells"},{"key":"3172_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ng.3224","volume":"47","author":"C Isella","year":"2015","unstructured":"Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, et al. Stromal contribution to the colorectal cancer transcriptome. Nat Genet. 2015;47:312\u20139.","journal-title":"Nat Genet"},{"key":"3172_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ng.3225","volume":"47","author":"A Calon","year":"2015","unstructured":"Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet. 2015;47:320\u20139.","journal-title":"Nat Genet"},{"key":"3172_CR9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.celrep.2015.01.040","volume":"10","author":"H Choi","year":"2015","unstructured":"Choi H, Sheng J, Gao D, Li F, Durrans A, Ryu S, et al. Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model. Cell Rep. 2015;10:1187\u2013201.","journal-title":"Cell Rep"},{"key":"3172_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-44518-8_1","volume":"1263","author":"F Montenegro","year":"2020","unstructured":"Montenegro F, Indraccolo S. Metabolism in the Tumor Microenvironment. Adv Exp Med Biol. 2020;1263:1\u201311.","journal-title":"Adv Exp Med Biol"},{"key":"3172_CR11","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1021\/acssensors.0c02267","volume":"5","author":"S Klinghammer","year":"2020","unstructured":"Klinghammer S, Voitsekhivska T, Licciardello N, Kim K, Baek C-K, Cho H, et al. Nanosensor-Based Real-Time Monitoring of Stress Biomarkers in Human Saliva Using a Portable Measurement System. ACS Sens. 2020;5:4081\u201391.","journal-title":"ACS Sens"},{"key":"3172_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/ijms18020294","volume":"18","author":"A Kot\u0142owska","year":"2017","unstructured":"Kot\u0142owska A, Puzyn T, Sworczak K, Stepnowski P. Metabolomic Biomarkers in Urine of Cushing\u2019s Syndrome Patients. Int J Mol Sci. 2017;18:294.","journal-title":"Int J Mol Sci"},{"key":"3172_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41416-019-0585-4","volume":"121","author":"AR Lima","year":"2019","unstructured":"Lima AR, Pinto J, Azevedo AI, Barros-Silva D, Jer\u00f3nimo C, Henrique R, et al. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine. Br J Cancer. 2019;121:857\u201368.","journal-title":"Br J Cancer"},{"key":"3172_CR14","first-page":"1413","volume":"42","author":"E Katsuta","year":"2019","unstructured":"Katsuta E, Maawy AA, Yan L, Takabe K. High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor\u2011positive breast cancer. Oncol Rep. 2019;42:1413\u201321.","journal-title":"Oncol Rep"},{"key":"3172_CR15","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1002\/j.1460-2075.1987.tb02740.x","volume":"6","author":"S Koyasu","year":"1987","unstructured":"Koyasu S, Tojo A, Miyajima A, Akiyama T, Kasuga M, Urabe A, et al. Interleukin 3-specific tyrosine phosphorylation of a membrane glycoprotein of Mr 150,000 in multi-factor-dependent myeloid cell lines. EMBO J. 1987;6:3979\u201384.","journal-title":"EMBO J"},{"key":"3172_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1022688","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang Y, Wang S, Ni H, Zhao P, Chen G, et al. The role of CXCR3 and its ligands in cancer. Front Oncol. 2022;12:1022688.","journal-title":"Front Oncol"},{"key":"3172_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2025.12.004","volume":"87","author":"O Hooks","year":"2025","unstructured":"Hooks O, Childers LT, Childers JT, Machado C, Mowers CC, Ahmad S. Role of anti-tumorigenic cytokines in gastrointestinal cancers. Cytokine Growth Factor Rev. 2025;87:54\u201363.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3172_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/biomedicines13030699","volume":"13","author":"U Silinskaite","year":"2025","unstructured":"Silinskaite U, Valciukiene J, Jakubauskas M, Poskus T. The Immune Environment in Colorectal Adenoma: A Systematic Review. Biomedicines. 2025;13:699.","journal-title":"Biomedicines"},{"key":"3172_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/jimr\/8890939","volume":"2025","author":"M Daghaighei","year":"2025","unstructured":"Daghaighei M, Dodge S, Bolandi S, Youssef B, Attarde N, Maddahi M, et al. The Multifaceted Role of the IL-2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation. J Immunol Res. 2025;2025:8890939.","journal-title":"J Immunol Res"},{"key":"3172_CR20","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3390\/cells14201594","volume":"14","author":"AL Shakerdi","year":"2025","unstructured":"Shakerdi AL, Finnegan E, Sheng Y-Y, Vidovic K, Logan JM, Ward MP, et al. Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer and Benign Disease: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities. Cells. 2025;14:1594.","journal-title":"Cells"},{"key":"3172_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/antiox13010119","volume":"13","author":"A Parascandolo","year":"2024","unstructured":"Parascandolo A, Benincasa G, Corcione F, Laukkanen MO. ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma. Antioxidants (Basel). 2024;13:119.","journal-title":"Antioxidants (Basel)"},{"key":"3172_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2468-2","volume":"11","author":"A Parascandolo","year":"2020","unstructured":"Parascandolo A, Bonavita R, Astaburuaga R, Sciuto A, Reggio S, Barra E, et al. Effect of naive and cancer-educated fibroblasts on colon cancer cell circadian growth rhythm. Cell Death Dis. 2020;11:289.","journal-title":"Cell Death Dis"},{"key":"3172_CR23","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1074\/jbc.RA117.000444","volume":"293","author":"K Bernard","year":"2018","unstructured":"Bernard K, Logsdon NJ, Benavides GA, Sanders Y, Zhang J, Darley-Usmar VM, et al. Glutaminolysis is required for transforming growth factor-\u03b21-induced myofibroblast differentiation and activation. J Biol Chem. 2018;293:1218\u201328.","journal-title":"J Biol Chem"},{"key":"3172_CR24","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/jnci\/djae047","volume":"116","author":"AM Bever","year":"2024","unstructured":"Bever AM, Hang D, Lee DH, Tabung FK, Ugai T, Ogino S, et al. Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk. J Natl Cancer Inst. 2024;116:1126\u201336.","journal-title":"J Natl Cancer Inst"},{"key":"3172_CR25","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.tem.2021.07.001","volume":"32","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou Q, Song S, Tang S. Integrating metabolic reprogramming and metabolic imaging to predict breast cancer therapeutic responses. Trends Endocrinol Metab. 2021;32:762\u201375.","journal-title":"Trends Endocrinol Metab"},{"key":"3172_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.trecan.2022.03.004","volume":"8","author":"Y Ohara","year":"2022","unstructured":"Ohara Y, Valenzuela P, Hussain SP. The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer. Trends Cancer. 2022;8:556\u201369.","journal-title":"Trends Cancer"},{"key":"3172_CR27","first-page":"2579","volume":"9","author":"G Lauren Lvd","year":"2008","unstructured":"Lauren Lvd G, Hinton G. Visualizing data using t-SNE. J Mach Learn Res. 2008;9:2579\u2013605.","journal-title":"J Mach Learn Res"},{"key":"3172_CR28","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","volume":"72","author":"T Fiaschi","year":"2012","unstructured":"Fiaschi T, Marini A, Giannoni E, Taddei ML, Gandellini P, De Donatis A, et al. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res. 2012;72:5130\u201340.","journal-title":"Cancer Res"},{"key":"3172_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ebiom.2018.07.002","volume":"33","author":"L Fuhr","year":"2018","unstructured":"Fuhr L, El-Athman R, Scrima R, Cela O, Carbone A, Knoop H, et al. The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer. EBioMedicine. 2018;33:105\u201321.","journal-title":"EBioMedicine"},{"key":"3172_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102057118","volume":"118","author":"W Palm","year":"2021","unstructured":"Palm W. Metabolic plasticity allows cancer cells to thrive under nutrient starvation. Proc Natl Acad Sci USA 2021;118:e2102057118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3172_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fonc.2020.00276","volume":"10","author":"JF Fahrmann","year":"2020","unstructured":"Fahrmann JF, Vykoukal JV, Ostrin EJ. Amino acid oncometabolism and immunomodulation of the tumor microenvironment in lung cancer. Front Oncol. 2020;10:276.","journal-title":"Front Oncol"},{"key":"3172_CR32","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/ijms18040878","volume":"18","author":"JF Coy","year":"2017","unstructured":"Coy JF. EDIM-TKTL1\/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of Cancer. Int J Mol Sci. 2017;18:878.","journal-title":"Int J Mol Sci"},{"key":"3172_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3892\/ol.2023.13851","volume":"25","author":"Y Xu","year":"2023","unstructured":"Xu Y, Dong X, Qin C, Wang F, Cao W, Li J, et al. Metabolic biomarkers in lung cancer screening and early diagnosis (Review). Oncol Lett. 2023;25:265.","journal-title":"Oncol Lett"},{"key":"3172_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer. 2024;10:627\u201342.","journal-title":"Trends Cancer"},{"key":"3172_CR35","unstructured":"Lea T. Caco-2 Cell Line. In: Verhoeckx K, Cotter P, L\u00f3pez-Exp\u00f3sito I, Kleiveland C, Lea T, Mackie A et al. (eds). The Impact of Food Bioactives on Health: in vitro and ex vivo models. Springer: Cham (CH), 2015 http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500149\/ (accessed 12 Dec2025)."},{"key":"3172_CR36","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1073\/pnas.0915135107","volume":"107","author":"TM Yeung","year":"2010","unstructured":"Yeung TM, Gandhi SC, Wilding JL, Muschel R, Bodmer WF. Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA 2010;107:3722\u20137.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03172-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:37:18Z","timestamp":1784086638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03172-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3172"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03172-1","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Ethical approvals for the isolation of the primary cells, tissues, and for the urine sample collection were obtained from the ethical committees of the Monaldi Hospital, Naples, Italy (Project 2013-01-02, deliberation number 1293), the University of Federico II of Naples, Naples, Italy (Protocol 394\/19), and the Clinical Mediterranea hospital, Naples, Italy (Authorization released by Medical Director on 24.5.2023). Informed consent was obtained from all participating patients. The study was performed in accordance with the Declaration of Helsinki. The funders had no role in the study\u2019s design, execution, data analysis, or interpretation of the results.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"306"}}